Skip to main content
. 2020 May 5;15(5):e0232773. doi: 10.1371/journal.pone.0232773

Fig 1. Re-treatment regimens after failure of an IFN-free DAA therapy.

Fig 1

Re-treatment regimens used after failure of a first IFN-free DAA therapy with SOF (A), SOF+SIM (B) SOF+DCV (C), SOF/LDV (D), OBV/PTV/r+DSV (E) and SOF/VEL (F) are shown. Abbreviations: DAA, direct-acting antiviral; DCV, daclatasvir; DSV, dasabuvir; GT, genotype; IFN, interferon; LDV, ledipasvir; OBV, ombitasvir; PTV, paritaprevir; r, ritonavir; RBV, ribavirin; SIM, simeprevir; SOF, sofosbuvir; SVR, sustained virological response; VEL, velpatasvir; VOX, voxilaprevir.